Simulations PlusFRA:SD3 67 EBIT per Share is €0.43 as of Feb. 2026. GuruFocus rates FRA:SD3 with a GF Score™ of 67/100 and a GF Value™ of €32.93 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 528 Healthcare Providers & Services companies, Simulations Plus ranks worse than 88.64% on this metric.
Simulations Plus's EBIT per Share for the
three
months ended in Feb. 2026 was €0.24.
Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 was €0.43.
During the past 12 months, the average EBIT per Share Growth Rate of Simulations Plus was 182.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -23.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -14.60% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -1.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Simulations Plus's EBIT per Share or its related term are showing as below:
FRA:SD3'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -23.4 Med: 12.8 Max: 84.8
Current: -23.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Simulations Plus was 84.80% per year. The lowest was -23.40% per year. And the median was 12.80% per year.
FRA:SD3's 3-Year EBIT Growth Rate is ranked worse than 88.64% of 528
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs FRA:SD3: -23.40
Simulations Plus (FRA:SD3) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Simulations Plus EBIT per Share Related Terms
Simulations Plus EBIT per Share Historical Data
* Premium members only.
The historical data trend for Simulations Plus's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.43
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simulations Plus (FRA:SD3) has a EBIT per Share of €0.43 as of Feb. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Simulations Plus and its competitors. According to the industry distribution chart, Simulations Plus ranks #468 out of 528 companies in the Healthcare Providers & Services industry, placing it in the top 88.6%.
Is Simulations Plus' EBIT per Share too high?
Simulations Plus' current EBIT per Share is €0.43. Based on the distribution chart, Simulations Plus ranks #468 out of 528 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Simulations Plus has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' EBIT per Share compare to TBRG and CARL?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #468 out of 528 companies for EBIT per Share. This places Simulations Plus in the lower half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 528 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Simulations Plus and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simulations Plus's current EBIT per Share is €0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (FRA:SD3) is currently considered Significantly Undervalued. The stock's GF Value™ is €32.93, compared to a current price of €15.80 — trading 52% below its estimated fair value. The current EBIT per Share is €0.43. Simulations Plus' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Simulations Plus (FRA:SD3), the current EBIT per Share is €0.43 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Simulations Plus (FRA:SD3) Overvalued in 2026?
Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued.
The current stock price of €15.80 is trading 52% below its estimated GF Value™ of €32.93.
GuruFocus considers Simulations Plus to be Significantly Undervalued.
Key valuation signals for FRA:SD3:
EBIT per Share: €0.43
GF Value™: €32.93 vs. price of €15.80 (52% below fair value)
No single metric tells the full story. See the FRA:SD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
67GF Score
Get the complete analysis for FRA:SD3
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:SD3 has been successfully added to your 
